Dec. 23, 2013, 7:32 AM
- ATMI (ATMI) has agreed to sell its LifeSciences unit to Pall Corp. (PLL) in a deal worth $185M, with after-tax proceeds to be $165M.
- The sale is part of ATMI's "ongoing exploration of strategic alternatives," the company said.
- The assets of the LifeSciences business include two Belgian sites and a shared facility in Minnesota. (PR)
Apr. 30, 2012, 3:24 AMPall Corp (PLL) said yesterday it will sell some of its blood collection, filtration and processing product lines to Haemonetics Corp (HAE) for ~$550M. Separately, Haemonetics announced it will acquire the business assets of Hemerus Medical, a company that develops innovative blood technologies. | Comment!
PLL vs. ETF Alternatives
Pall Corporation supplies filtration, separation and purification technologies, using its fluid clarification and separations equipment for the removal of solid, liquid and gaseous contaminants from a wide variety of liquids and gases.
Other News & PR